Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 17, 2023 08:00 ET | Source: Ultragenyx Pharmaceutical Inc.

Ultragenyx Receives FDA Agreement to Expand Ongoing Global Phase 1/2 Trial Evaluating GTX-102 in Patients with Angelman Syndrome in the U.S.

NOVATO, Calif., May 17, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that the U.S. Food and Drug Administration (FDA) has reviewed and agreed to a protocol...
May 17, 2023 08:00 ET | Source: Achieve Life Sciences

Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank

SEATTLE and VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
May 17, 2023 08:00 ET | Source: Immutep Limited

Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer

Media Release Immuno-oncology combination of eftilagimod alpha (efti) and the leading anti-PD-1 therapy generates meaningful long-term survival in non-small cell lung cancer patients in Phase II...
May 17, 2023 08:00 ET | Source: Heart Test Laboratories, Inc.

HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine

Southlake, Texas, May 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
May 17, 2023 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON to Present Trial in Progress Phase Ib FRIDA Study at the Upcoming 2023 ASCO Annual Meeting

MADRID, Spain and BOSTON, May 17, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop...
May 17, 2023 07:30 ET | Source: Growth Plus Reports

Anti-parathyroid Agents Market Set to Register a CAGR of 5.2% from 2023 to 2031 | Growth Plus Reports

Newark, New Castle, USA, May 17, 2023 (GLOBE NEWSWIRE) -- According to a recent report published by Growth Plus Reports, the anti-parathyroid agents market is projected to register a CAGR of 5.2%...
May 17, 2023 07:30 ET | Source: Ardelyx, Inc.

Ardelyx Announces FDA Acceptance and Six-Month Review for Resubmission of its New Drug Application of XPHOZAH® (tenapanor)

WALTHAM, Mass., May 17, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class...
May 17, 2023 07:30 ET | Source: BrainsWay

BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights

BURLINGTON, Mass. and JERUSALEM, May 17, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for...
May 17, 2023 07:00 ET | Source: Elevar Therapeutics

Elevar Therapeutics Submits New Drug Application to FDA for Combination of Rivoceranib and Camrelizumab as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma

FORT LEE, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a wholly owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
May 17, 2023 07:00 ET | Source: Kamada Ltd.

Kamada to Announce First Quarter 2023 Financial Results and Host Conference Call on May 24, 2023

REHOVOT, Israel and HOBOKEN, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products...
May 17, 2023 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Pharmacology and Medicinal Chemistry Results that Reveal the Molecular Mechanism of Action of Tianeptine, the Active Ingredient of TNX-601 ER, in Treating Depression

Research Supports Direct Role for Restoring Neuroplasticity and Upsets Previously Held Beliefs About the Significance of Neurotransmitters in Treating Depression Findings Explain Why Tianeptine Is...
May 17, 2023 07:00 ET | Source: Nexstim Oyj

Nexstim’s Quality System and NBS 6 Receive MDR Certification in the EU

Press release, Helsinki, 17 May 2023 at 2 PM (EEST) Nexstim’s Quality System and NBS 6 Receive MDR Certification in the EU Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received...
May 17, 2023 07:00 ET | Source: Medunik USA

Pheburane® Expanded Coverage with Commercial and Government (Medicaid) Payers

PRINCETON, NJ, 17 mai 2023 (GLOBE NEWSWIRE) -- Medunik USA (member of Duchesnay Pharmaceutical Group) is pleased to announce that Pheburane® is now covered with preferred status at key pharmacy...
May 17, 2023 07:00 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Announces Chief Medical Officer Invited to Give Presentation on Intranasal Foralumab on May 17

NEW YORK, May 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
May 17, 2023 06:30 ET | Source: Transparency Market Research

Rare Kidney Diseases Treatment Market Forecasted to Hit US$ 4.6 Billion by 2031, growing at a 5.8% CAGR | Transparency Market Research

Wilmington, Delaware, United States, May 17, 2023 (GLOBE NEWSWIRE) -- The global rare kidney disease treatment market is expected to grow at a 5.8% CAGR from 2023 to 2031. A market valuation of US$...
May 17, 2023 06:13 ET | Source: Research and Markets

PTA Balloon Catheter Global Market Report 2023: Increasing Prevalence of Cardiovascular Disorders Bolsters Growth

Dublin, May 17, 2023 (GLOBE NEWSWIRE) -- The "PTA Balloon Catheter Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global PTA balloon catheter market is...
May 17, 2023 06:10 ET | Source: SPHERICAL INSIGHTS LLP

Global Bariatric Surgery Devices Market Size To Worth USD 3.67 Billion By 2030 | CAGR 6.5%

New York, United States , May 17, 2023 (GLOBE NEWSWIRE) -- The Global Bariatric Surgery Devices Market Size to Grow from USD 2.5 Billion in 2021 to USD 3.67 Billion by 2030, at a Compound Annual...
May 17, 2023 06:08 ET | Source: Market.Us

Wearable Injectors Market Size Is Projected To Surpass USD 20.9 billion by 2032 || CAGR of 12.4%

New York, May 17, 2023 (GLOBE NEWSWIRE) -- The wearable injectors market will witness a robust CAGR of 12.4%, valued at USD 6.7 billion in 2022, and expected to appreciate and reach USD 20.9 billion...
May 17, 2023 05:00 ET | Source: Global Market Insights Inc.

Polystyrene Packaging Market to Hit $3 Bn By 2032, Says Global Market Insights Inc.

Selbyville, Delaware,, May 17, 2023 (GLOBE NEWSWIRE) -- The polystyrene packaging market valuation is anticipated to surpass USD 3 billion by 2032, as reported in a research study by Global Market...
May 17, 2023 04:58 ET | Source: Research and Markets

The Medical Device School - From Concept to CE Marking Training Course (June 12-16, 2023)

Dublin, May 17, 2023 (GLOBE NEWSWIRE) -- The "The Medical Device School - From Concept to CE Marking Training Course" conference has been added to ResearchAndMarkets.com's offering. Bringing a...
May 17, 2023 03:59 ET | Source: Market.Us

Patient Registry Software Market Sales to Top US$ 3,632 Million in Revenues by 2032 || CAGR of 12%

New York, May 17, 2023 (GLOBE NEWSWIRE) -- The Patient Registry Software Market was valued at USD 1,200 Million in 2022 and is expected to reach a value of USD 3,632 Million by 2032. In the...
May 17, 2023 01:00 ET | Source: F. Hoffmann-La Roche Ltd

Roche’s BTK inhibitor fenebrutinib significantly reduced brain lesions in people with relapsing forms of multiple sclerosis

Fenebrutinib is an investigational, potent and highly selective oral Bruton’s tyrosine kinase (BTK) inhibitor, the only reversible BTK inhibitor currently in Phase III multiple sclerosis (MS)...
May 17, 2023 01:00 ET | Source: BioSenic

BioSenic récupère les droits de propriété intellectuelle au niveau mondial et fait le point sur le développement de JTA-004

INFORMATION PRIVILEGIEE BioSenic prévoit de poursuivre le développement de son programme sur un viscosupplément injectable actif JTA, combinant des caractéristiques anti-douleur et...
May 17, 2023 01:00 ET | Source: BioSenic

BioSenic reacquires global IP rights and provides update on JTA-004 development

INSIDE INFORMATION BioSenic plans to further develop its program on an active injectable viscosupplement JTA, combining anti-pain and anti-inflammatory characteristics on a subtype of knee...
May 16, 2023 18:51 ET | Source: Love Pharma

LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO “JOLT HEALTH INC.” AND INCREASED FOCUS ON BIOTECHNOLOGY

VANCOUVER, BC, CANADA, May 16, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased to announce that it has changed its name to “Jolt Health...
May 16, 2023 17:00 ET | Source: Infant Bacterial Therapeutics AB

IBT beslutar om en företrädesemisson

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, HELT ELLER DELVIS, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, KANADA, NYA ZEELAND, HONGKONG, JAPAN, SCHWEIZ, SINGAPORE, SYDAFRIKA,...
May 16, 2023 17:00 ET | Source: Infant Bacterial Therapeutics AB

IBT resolves on a rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND,...
May 16, 2023 17:00 ET | Source: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Receives FDA Orphan Drug Designation for the Fixed-Dose Combination of OCA and Bezafibrate for the Treatment of Primary Biliary Cholangitis (PBC)

Company on track to complete planned interim analyses from two ongoing Phase 2 studies of the OCA-bezafibrate combination in 2023 Results from planned interim analysis of Phase 2 study evaluating the...
May 16, 2023 16:56 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Chinook Therapeutics (KDNY) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, May 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Chinook Therapeutics, Inc. (NASDAQ: KDNY) investors who suffered substantial losses to submit your losses now. Visit:...
May 16, 2023 16:40 ET | Source: Trexo Robotics

Trexo Robotics Announces New York Family’s Victory in Funding Appeal, Allowing an 11-year-old Boy Long Term Access to Robotic Legs

NEW YORK, May 16, 2023 (GLOBE NEWSWIRE) -- Trexo Robotics brought to market the only at-home robotic gait trainer for children. The device is state-of-the-art robotic legs, attached to a Rifton...
May 16, 2023 16:30 ET | Source: Editas Medicine, Inc.

Editas Medicine Announces Appointment of Erick J. Lucera as Chief Financial Officer

CAMBRIDGE, Mass., May 16, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the appointment of Erick J. Lucera as Executive...
May 16, 2023 16:15 ET | Source: Bioventus, Inc.

Bioventus Reports First Quarter Financial Results

DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
May 16, 2023 16:05 ET | Source: Beyond Air™

Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast

GARDEN CITY, N.Y., May 16, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO)...
May 16, 2023 16:05 ET | Source: BioVie, Inc.

BioVie Presents Rationale for Potentially Pivotal Trial of NE3107 in the Treatment of Parkinson’s Disease at 2023 International Association of Parkinsonism and Related Disorders World Congress

CARSON CITY, Nev., May 16, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of...
May 16, 2023 16:05 ET | Source: Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals Announces Closing of $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer...
May 16, 2023 16:05 ET | Source: Aspira Women's Health Inc.

Aspira Women’s Health Names Torsten Hombeck as Chief Financial Officer

AUSTIN, Texas, May 16, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease...
May 16, 2023 16:05 ET | Source: Nyxoah

Nyxoah Présente ses Résultats Financiers et Opérationnels pour le Premier Trimestre 2023

INFORMATIONS RÉGLEMENTÉES Nyxoah Présente ses Résultats Financiers et Opérationnels pour le Premier Trimestre 2023 Mont-Saint-Guibert, Belgique – 16 Mai 2023, 22h05 CET / 16h05 ET – Nyxoah...
May 16, 2023 16:05 ET | Source: Nyxoah

Nyxoah Reports First Quarter 2023 Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports First Quarter 2023 Financial and Operating Results Mont-Saint-Guibert, Belgium – May 16, 2023 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext...
May 16, 2023 16:01 ET | Source: Mydecine Innovations Group Inc.

Mydecine Reports Financial Results for the First Quarter of Fiscal Year 2023

VANCOUVER, British Columbia, May 16, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company engineering the...
May 16, 2023 16:01 ET | Source: X4 Pharmaceuticals

X4 Pharmaceuticals Announces Positive Phase 3 Results Showing Mavorixafor Reduced the Rate, Severity, and Duration of Infections vs. Placebo in Participants Diagnosed with WHIM Syndrome

~60% reduction in annualized infection rate seen in the mavorixafor arm vs. placebo (p<0.01) >75% reduction in the percentage of individuals experiencing severe infections (Grade 3 or higher)...
May 16, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Chronic Hepatitis B Market to Observe Stunning Growth at a CAGR of 13.4% by 2032 | DelveInsight

New York, USA, May 16, 2023 (GLOBE NEWSWIRE) -- Chronic Hepatitis B Market to Observe Stunning Growth at a CAGR of 13.4% by 2032 | DelveInsight The chronic hepatitis B market is expected to grow...
May 16, 2023 12:50 ET | Source: Levi & Korsinsky, LLP

FULC LAWSUIT ALERT: Levi & Korsinsky Notifies Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, May 16, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ: FULC) of a class action securities...
May 16, 2023 11:53 ET | Source: Research and Markets

Global Bioprocess Validation Market Report 2023: Sector is Expected to Reach $842.5 Million by 2030 at a CAGR of 9.10%

Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Bioprocess Validation Market Size, Share & Trends Analysis Report By Testing Type (Extractables & Leachables Testing, Bioprocess Residuals...
May 16, 2023 11:13 ET | Source: Research and Markets

Global Gastroesophageal Reflux Disease Therapeutics Market Report 2023: Rising Prevalence of GERD and Other Gastrointestinal Disorders Drives Growth

Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor...
May 16, 2023 11:00 ET | Source: FACT.MR

Carglumic Acid Market Size to Reach US$ 314.4 million in 2033; Treatment of Hyperammonemia to Drive the Market Growth | Fact.MR's Study

Rockville, May 16, 2023 (GLOBE NEWSWIRE) -- Fact.MR has provided detailed information about the price points of key manufacturers of carglumic acid positioned across regions, sales growth,...
May 16, 2023 10:35 ET | Source: Market Research Future

OEM Patient Monitoring and Vital Sign OEM Module Market Size Worth USD 22.44 Billion by 2030 at 7.98% CAGR – Report by Market Research Future (MRFR)

New York, USA, May 16, 2023 (GLOBE NEWSWIRE) -- OEM Patient Monitoring and Vital Sign OEM Module Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR),"OEM...
May 16, 2023 10:30 ET | Source: Market Research Future

Precision Medicine Market Size to Surpass USD 126.24 Billion by 2030 at 12.50% CAGR – Report by Market Research Future (MRFR)

New York, USA, May 16, 2023 (GLOBE NEWSWIRE) -- Precision Medicine Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Precision Medicine Market...
May 16, 2023 10:30 ET | Source: Transparency Market Research

Industrial Hose Market Sales to Hit US$ 22.8 Billion by 2031, Owing to Adoption in Construction and Automotive Industries - Transparency Market Research Report

Wilmington, Delaware, United States, May 16, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Continuous development of industrial hose systems used by end-use industries in the...
May 16, 2023 09:58 ET | Source: Research and Markets

mRNA Vaccine and Therapeutics Market Insights, Competitive Landscape, and Market Forecasts, 2027

Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "mRNA Vaccine and Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2027" report has been added to ResearchAndMarkets.com's...
May 16, 2023 09:51 ET | Source: Market Research Future

Quality Management Software Market Size to Reach USD 16.10 Billion, With a CAGR of 10.40% CAGR by 2030 - Report by Market Research Future (MRFR)

New York, US, May 16, 2023 (GLOBE NEWSWIRE) -- According to a Comprehensive Research Report by Market Research Future (MRFR), Quality Management Software Market Information By Solution Type, By...